Restriction of Human Cytomegalovirus Infection by Galectin-9
- 1 February 2019
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 93 (3)
Abstract
Human cytomegalovirus (HCMV) continues to cause serious and often life-threatening disease in those with impaired or underdeveloped immune systems. This virus is able to infect and replicate in a wide range of human cell types, which enables the virus to spread to other individuals in a number of settings. Current antiviral drugs are associated with a significant toxicity profile, and there is no vaccine; these factors highlight a need to identify additional targets for the development of anti-HCMV therapies. We demonstrate for the first time that secretion of a member of the galectin family of proteins, galectin-9 (Gal-9), is upregulated during natural HCMV-reactivated infection and that this soluble cellular protein possesses a potent capacity to block HCMV infection by inhibiting virus entry into the host cell. Our findings support the possibility of harnessing the antiviral properties of Gal-9 to prevent HCMV infection and disease.Keywords
Funding Information
- Department of Health | National Health and Medical Research Council
- HHS | NIH | National Institute of Allergy and Infectious Diseases (AI101423)
This publication has 93 references indexed in Scilit:
- Dysregulated Tim-3 expression on natural killer cells is associated with increased Galectin-9 levels in HIV-1 infectionRetrovirology, 2013
- A Myeloid Progenitor Cell Line Capable of Supporting Human Cytomegalovirus Latency and Reactivation, Resulting in Infectious ProgenyJournal of Virology, 2012
- Galectin-1-Specific Inhibitors as a New Class of Compounds To Treat HIV-1 InfectionAntimicrobial Agents and Chemotherapy, 2012
- Galectin-9 binding to cell surface protein disulfide isomerase regulates the redox environment to enhance T-cell migration and HIV entryProceedings of the National Academy of Sciences, 2011
- Antiviral Drug Resistance of Human CytomegalovirusClinical Microbiology Reviews, 2010
- Sequential mutations associated with adaptation of human cytomegalovirus to growth in cell cultureJournal of General Virology, 2010
- Acquisition of Polyfunctionality by Epstein-Barr Virus-Specific CD8 + T Cells Correlates with Increased Resistance to Galectin-1-Mediated SuppressionJournal of Virology, 2009
- HCMV gH/gL/UL128–131 interferes with virus entry into epithelial cells: Evidence for cell type-specific receptorsProceedings of the National Academy of Sciences, 2008
- Phosphorothioate-Modified Oligodeoxynucleotides Inhibit Human Cytomegalovirus Replication by Blocking Virus EntryAntimicrobial Agents and Chemotherapy, 2008
- Functions of cell surface galectin-glycoprotein latticesCurrent Opinion in Structural Biology, 2007